Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05399329 |
|---|---|
| Brief Title: | Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan |
| First Submitted : | May 26, 2022 |
| First Submitted that Met QC Criteria : | May 26, 2022 |
| First Posted : | June 1, 2022 |
| Last Update Submitted that Met QC Criteria : | December 15, 2022 |
| Last Update Posted : | December 16, 2022 |